Xiaobin Lv
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 5%
- RNA modifications and cancer
- Circular RNAs in diseases
- RNA Research and Splicing
- Epigenetics and DNA Methylation
- Cancer-related gene regulation
Papers in ⓘ
-
- Cancer-related molecular mechanisms research 18
- MicroRNA in disease regulation 12
-
- RNA modifications and cancer 13
- RNA Research and Splicing 8
- Circular RNAs in diseases 6
- Histone Deacetylase Inhibitors Research 3
- Co-authors
- Erwei Song (6 shared papers)Herui Yao (3 shared papers)Qiang Liu (3 shared papers)Bodu Liu (3 shared papers)Lijuan Sun (3 shared papers)Dangsheng Li (1 shared paper)Fengxi Su (1 shared paper)Yandan Yao (1 shared paper)
- Journals
- Clinical Cancer Research (2 papers)Cell Biology International (2 papers)Cancer Cell International (2 papers)Journal of Biological Chemistry (2 papers)Oncotarget (2 papers)
- Partner nations
- ChinaSouth KoreaUnited States
In The Last Decade
Xiaobin Lv
31 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 95
- Cancer Research 1.5k
- Molecular Biology 1.6k
- Oncology 189
- Immunology 130
- Epidemiology 115
Countries citing papers authored by Xiaobin Lv
This map shows the geographic impact of Xiaobin Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaobin Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaobin Lv more than expected).
Fields of papers citing papers by Xiaobin Lv
This network shows the impact of papers produced by Xiaobin Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaobin Lv. The network helps show where Xiaobin Lv may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaobin Lv, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Cytoplasmic NF-κB Interacting Long Noncoding RNA Blocks IκB Phosphorylation and Suppresses Breast Cancer Metastasis Hit paper breakdown → | 2015 | 746 |
| 2 | 2013 | 140 | |
| 3 | 2011 | 125 | |
| 4 | 2015 | 101 | |
| 5 | 2013 | 101 | |
| 6 | 2013 | 76 | |
| 7 | 2015 | 67 | |
| 8 | 2011 | 64 | |
| 9 | 2019 | 60 | |
| 10 | 2016 | 57 | |
| 11 | 2015 | 57 | |
| 12 | 2017 | 52 | |
| 13 | 2018 | 51 | |
| 14 | miR-148b functions as a tumor suppressor in non-small cell lung cancer by targeting carcinoembryonic antigen (CEA). | 2014 | 29 |
| 15 | 2021 | 24 | |
| 16 | 2013 | 22 | |
| 17 | 2020 | 19 | |
| 18 | 2015 | 16 | |
| 19 | 2021 | 15 | |
| 20 | 2019 | 14 |
About Xiaobin Lv
Xiaobin Lv is a scholar working on Cancer Research, Molecular Biology, Endocrinology, Oncology and Pulmonary and Respiratory Medicine, having authored 31 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (18 papers), RNA modifications and cancer (13 papers), MicroRNA in disease regulation (12 papers), RNA Research and Splicing (8 papers), Circular RNAs in diseases (6 papers), Histone Deacetylase Inhibitors Research (3 papers), Peptidase Inhibition and Analysis (2 papers) and Cytokine Signaling Pathways and Interactions (2 papers). The work is most often cited by research in Cancer Research (1.5k citations), Molecular Biology (1.6k citations), Oncology (189 citations), Immunology (130 citations) and Epidemiology (115 citations). Xiaobin Lv has collaborated with scholars based in China, South Korea and United States. Frequent co-authors include Erwei Song, Herui Yao, Qiang Liu, Bodu Liu, Lijuan Sun, Dangsheng Li, Fengxi Su, Yandan Yao, Ling Lin and Chang Gong. Their work appears in journals such as Clinical Cancer Research, Cell Biology International, Cancer Cell International, Journal of Biological Chemistry and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.